Difficulty: Medium
Average Score: 65%
Practice
A 41-year-old woman with acute myelogenous leukemia is undergoing a weekly intravenous infusion of chemotherapeutic agents. Upon completion of each cycle, she develops severe nausea and vomiting. A pharmacologic agent is administered intravenously, which seems to decrease nausea in this patient. This agent might have a mechanism of action at which of the following receptors?
Correct answer
C
Rationale
Ondansetron, a 5-HT3 receptor antagonist, is commonly used IV to block serotonin-mediated nausea and vomiting induced by chemotherapy.